Rotavirus Vaccine
Not recommended Immunology
prevention of rotavirus gastroenteritis in infants and children
1
Submissions
2006–06
On the record
$15k–45k
ICER range
1 sourced ICER · 2006
ICER stated
Cost basis
Cost-effectiveness
Economic model disputed
Decision context
Populationinfants and children
Why it was knocked back
- uncertain cost-effectiveness at the price requested, framing bias in disutility elicitation for QALY calculation, uncertainty about willingness-to-pay valuation methodology, administration costs not included in economic model, insufficient information on cost-effectiveness in restricted Aboriginal and Torres Strait Islander population
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Jul 2006 | Not recommended | placebo (standard medical management) | $15k–45k | RCT |